SCHEMBL14064672

SCHEMBL14064672

CCCc1ccc(-c2n[nH]c(=O)c3ccccc23)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
KDM4E B2RXH2 2/20 0.58
ENPP1 P22413 1/20 0.58
ROCK1 Q13464 10/20 0.56
ROCK2 O75116 7/20 0.56
NCOA1 Q15788 1/20 0.55
NCOA3 Q9Y6Q9 1/20 0.55
MAPK1 P28482 1/20 0.55
ALDH1A1 P00352 1/20 0.52
POLB P06746 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
ALOX15 P16050 1/20 0.52
HSD17B10 Q99714 1/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3969988 0.90 ATM (0.58) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL31014274 0.88 ATM (0.67) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL15880419 0.81 ATM (0.67) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL24000694 0.81 ENPP1 (0.67) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL31384270 0.80 ENPP1 (0.67) ATMNPSR1KDM4EENPP1ROCK1
Hydrochloric Acid SCHEMBL30089010 0.80 ATM (0.65) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL19675414 0.79 ROCK1 (0.67) ATMNPSR1KDM4EROCK1ROCK2
Hydrochloric Acid SCHEMBL30088814 0.79 ENPP1 (0.66) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL1786578 0.79 ATM (0.73) ATMNPSR1KDM4EENPP1ROCK1
SCHEMBL19675093 0.79 ROCK1 (0.60) KDM4EROCK1ROCK2NCOA1NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425563-B2 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-09-16 US disclosed